Skip to content

Main Navigation

Fennec Pharmaceuticals
Fennec Pharmaceuticals
  • For Families
    • Advocacy Groups
    • Family Stories
    • Named Patient Access
  • Product
  • Science
    • Cisplatin-Induced Hearing Loss
  • About Us
    • Our Mission
    • Our Team
    • Careers
  • Investors
    • Corporate Profile
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
  • Contact Us
  • For Families
    • Advocacy Groups
    • Family Stories
    • Named Patient Access
  • Product
  • Science
    • Cisplatin-Induced Hearing Loss
  • About Us
    • Our Mission
    • Our Team
    • Careers
  • Investors
    • Corporate Profile
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
  • Contact Us

Helping kids hear the future

Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.

Discover what we stand for
Explore what we’re focused on
See product details

Latest News

  • FENNEC ANNOUNCES RESULTS OF ANNUAL MEETINGJune 3, 2025
  • FENNEC PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATEMay 13, 2025
  • FENNEC PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 13, 2025May 8, 2025
  • FENNEC PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATEMarch 10, 2025
  • FENNEC PHARMACEUTICALS TO REPORT FULL YEAR AND FOURTH QUARTER 2024 FINANCIAL RESULTS ON MARCH 10, 2025March 10, 2025
See More

Resources

For Investors
For Families

You are now leaving Fennec Pharmaceuticals to access a product-specific website intended for US citizens only.

Please visit us again soon!

Continue

Fennec® is a registered trademark of Fennec Pharmaceuticals Inc.
©2025 Fennec Pharmaceuticals Inc. All rights reserved. FEN-1538-v4 3/24

  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Careers
  • Sitemap